• Immunohistochemistry analysis of paraffin-embedded human breast carcinoma tissue, using FA7 (light chain, Cleaved-Arg212) Antibody. The picture on the right is blocked with the synthesized peptide.
  • Western blot analysis of lysates from Jurkat cells, treated with eto 25uM 24h, using FA7 (light chain, Cleaved-Arg212) Antibody. The lane on the right is blocked with the synthesized peptide.
  • Western blot analysis of various cells using Cleaved-Factor VII LC (R212) Polyclonal Antibody

Anti-Cleaved-F7-R212 antibody (171-220 aa) (STJ90080)

SKU:
STJ90080

£46.00 - £226.00
Current Stock:
Host: Rabbit
Applications: WB/IHC/IF/ELISA
Reactivity: Human/Rat/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Cleaved-Coagulation factor VII-R212 (171-220 aa) is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
IHC 1:100-1:300
ELISA 1:20000
IF 1:50-200
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: F7
Gene ID: 2155
Uniprot ID: FA7_HUMAN
Immunogen Region: 171-220 aa
Specificity: Cleaved-Factor VII LC (R212) Polyclonal Antibody detects endogenous levels of fragment of activated Factor VII LC protein resulting from cleavage adjacent to R212.
Immunogen: The antiserum was produced against synthesized peptide derived from the human FA7 at the amino acid range 171-220
Post Translational Modifications The vitamin K-dependent, enzymatic carboxylation of some glutamate residues allows the modified protein to bind calcium. The iron and 2-oxoglutarate dependent 3-hydroxylation of aspartate and asparagine is (R) stereospecific within EGF domains. O- and N-glycosylated. N-glycosylation at Asn-205 occurs cotranslationally and is mediated by STT3A-containing complexes, while glycosylation at Asn-382 is post-translational and is mediated STT3B-containing complexes before folding. O-fucosylated by POFUT1 on a conserved serine or threonine residue found in the consensus sequence C2-X(4,5)-S/T-C3 of EGF domains, where C2 and C3 are the second and third conserved cysteines. Can be either O-glucosylated or O-xylosylated at Ser-112 by POGLUT1 in vitro.
Function Initiates the extrinsic pathway of blood coagulation. Serine protease that circulates in the blood in a zymogen form. Factor VII is converted to factor VIIa by factor Xa, factor XIIa, factor IXa, or thrombin by minor proteolysis. In the presence of tissue factor and calcium ions, factor VIIa then converts factor X to factor Xa by limited proteolysis. Factor VIIa will also convert factor IX to factor IXa in the presence of tissue factor and calcium.
Protein Name Coagulation Factor Vii
Proconvertin
Serum Prothrombin Conversion Accelerator
Spca
Eptacog Alfa Cleaved Into - Factor Vii Light Chain - Factor Vii Heavy Chain
Database Links Reactome: R-HSA-1368108
Reactome: R-HSA-140834
Reactome: R-HSA-159740
Reactome: R-HSA-159763
Reactome: R-HSA-159782
Cellular Localisation Secreted
Alternative Antibody Names Anti-Coagulation Factor Vii antibody
Anti-Proconvertin antibody
Anti-Serum Prothrombin Conversion Accelerator antibody
Anti-Spca antibody
Anti-Eptacog Alfa Cleaved Into - Factor Vii Light Chain - Factor Vii Heavy Chain antibody
Anti-F7 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance